Post

New research · Ophthalmology
NPJ digital medicine · 23h
AI / informaticsNPJ digital medicine · 2025

ROFI: a deep learning-based ophthalmic sign-preserving and reversible patient face anonymizer.

Yuan Tian, Min Zhou, Yitong Chen … Xianqun Fan
Read paper
OphthalmologyAI / informatics

ROFI maintains 100% diagnostic sensitivity for eye diseases while anonymizing patient faces.

ROFI: a deep learning-based ophthalmic sign-preserving and reversible patient face anonymizer.

Yuan Tian et al. · NPJ digital medicine · 2025
Background

Patient face images provide a convenient mean for evaluating eye diseases, while also raising privacy concerns.

Results
diagnostic sensitivity
ROFI correctly found every case of eye disease
More results

Here, we introduce ROFI, a deep learning-based privacy protection framework for ophthalmology.

Using weakly supervised learning and neural identity translation, ROFI anonymizes facial features while retaining disease features (over 98% accuracy, κ > 0.90).

More results

ROFI works with AI systems, maintaining original diagnoses (κ > 0.80), and supports secure image reversal (over 98% similarity), enabling audits and long-term care.

“
Conclusion

These results show ROFI's effectiveness of protecting patient privacy in the digital medicine era.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
10.50-point increase
students trained with digital patients had higher history-taking assessment scores
Case-control
0 of 28
distinct structural changes were absent in all 28 healthy control eyes
Cohort Study
RR, 0.91
Black patients were less likely to start medication for their eye condition
AI / Informatics
difference, 0
AI and human experts had the same median quality scores for eye care questions
AI / Informatics
0.877
The o1 large language model correctly answered 87.7% of ophthalmology questions.
Cohort Study
HR 4.85
chronic pain conditions mean a nearly five times higher risk of developing dry eye disease
Cohort Study
12 per 10,000
a higher rate of eye infections after dexamethasone implant injections
Guideline
first 5 years
annual eye screening for damage can be delayed for this long if no risk factors